{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:24:23Z","timestamp":1750202663031,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007113","name":"Arak University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007113","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-023-05563-1","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T03:02:01Z","timestamp":1701313321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 vaccine\u2013induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-9319","authenticated-orcid":false,"given":"Akbar","family":"Dorgalaleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-163X","authenticated-orcid":false,"given":"Ashkan","family":"Shabannezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-9987","authenticated-orcid":false,"given":"Saeed","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"6","key":"5563_CR1","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00277-023-05234-1","volume":"102","author":"M Sayyadi","year":"2023","unstructured":"Sayyadi M, Hassani S, Shams M, Dorgalaleh A (2023) Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement. Ann Hematol 102(6):1307\u20131322. https:\/\/doi.org\/10.1007\/s00277-023-05234-1","journal-title":"Ann Hematol"},{"issue":"7","key":"5563_CR2","doi-asserted-by":"publisher","first-page":"e6011","DOI":"10.1002\/ccr3.6011","volume":"10","author":"R Sarmadian","year":"2022","unstructured":"Sarmadian R, Ghasemikhah R, Sarmadian H, Khosravi M, Hassani S (2022) Post-COVID-19 splenic infarction in a patient with chronic atrial fibrillation: a case report. Clin Case Rep 10(7):e6011. https:\/\/doi.org\/10.1002\/ccr3.6011","journal-title":"Clin Case Rep"},{"issue":"1","key":"5563_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","volume":"100","author":"H-c Luo","year":"2021","unstructured":"Luo H-c, You C-y, Lu S-w, Fu Y-q (2021) Characteristics of coagulation alteration in patients with COVID-19. Ann Hematol 100(1):45\u201352. https:\/\/doi.org\/10.1007\/s00277-020-04305-x","journal-title":"Ann Hematol"},{"key":"5563_CR4","doi-asserted-by":"publisher","unstructured":"Rad F, Dabbagh A, Dorgalaleh A, Biswas A (2021) The relationship between inflammatory cytokines and coagulopathy in patients with COVID-19. J Clin Med 10(9). https:\/\/doi.org\/10.3390\/jcm10092020","DOI":"10.3390\/jcm10092020"},{"issue":"8","key":"5563_CR5","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","volume":"106","author":"K Althaus","year":"2021","unstructured":"Althaus K, M\u00f6ller P, Uzun G et al (2021) Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 106(8):2170\u20132179. https:\/\/doi.org\/10.3324\/haematol.2021.279000","journal-title":"Haematologica"},{"issue":"22","key":"5563_CR6","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021) Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 384(22):2092\u20132101. https:\/\/doi.org\/10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"issue":"33","key":"5563_CR7","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1016\/j.vaccine.2022.06.014","volume":"40","author":"M Nunes","year":"2022","unstructured":"Nunes M, de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V et al (2022) Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: description of a series of 39 cases in Brazil. Vaccine 40(33):4788\u20134795. https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.014","journal-title":"Vaccine"},{"issue":"23","key":"5563_CR8","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R et al (2021) Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(23):2202\u20132211. https:\/\/doi.org\/10.1056\/NEJMoa2105385","journal-title":"N Engl J Med"},{"issue":"14","key":"5563_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1182\/blood.2021013362","volume":"138","author":"GM Arepally","year":"2021","unstructured":"Arepally GM (2021) COVID-19 and VITT: same or different? Blood 138(14):1206\u20131207. https:\/\/doi.org\/10.1182\/blood.2021013362","journal-title":"Blood"},{"issue":"01","key":"5563_CR10","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1055\/s-0041-1736166","volume":"48","author":"M Bahraini","year":"2021","unstructured":"Bahraini M, Dorgalaleh A (2021) The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19. Semin Thromb Hemost 48(01):019\u2013030. https:\/\/doi.org\/10.1055\/s-0041-1736166","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"5563_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1055\/s-0040-1713434","volume":"46","author":"A Dorgalaleh","year":"2020","unstructured":"Dorgalaleh A (2020) Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost 46(07):815\u2013818. https:\/\/doi.org\/10.1055\/s-0040-1713434","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"5563_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","volume":"19","author":"DA Gorog","year":"2022","unstructured":"Gorog DA, Storey RF, Gurbel PA et al (2022) Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 19(7):475\u2013495. https:\/\/doi.org\/10.1038\/s41569-021-00665-7","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"5563_CR13","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","volume":"385","author":"S Pavord","year":"2021","unstructured":"Pavord S, Scully M, Hunt BJ et al (2021) Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med 385(18):1680\u20131689. https:\/\/doi.org\/10.1056\/NEJMoa2109908","journal-title":"N Engl J Med"},{"issue":"14","key":"5563_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1182\/blood.2022017696","volume":"141","author":"DB Cines","year":"2023","unstructured":"Cines DB, Greinacher A (2023) Vaccine-induced immune thrombotic thrombocytopenia. Blood 141(14):1659\u20131665. https:\/\/doi.org\/10.1182\/blood.2022017696","journal-title":"Blood"},{"issue":"22","key":"5563_CR15","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz NH, S\u00f8rvoll IH, Michelsen AE et al (2021) Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(22):2124\u20132130. https:\/\/doi.org\/10.1056\/NEJMoa2104882","journal-title":"N Engl J Med"},{"issue":"4","key":"5563_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1182\/blood.2021011958","volume":"138","author":"A Tiede","year":"2021","unstructured":"Tiede A, Sachs UJ, Czwalinna A et al (2021) Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood 138(4):350\u2013353. https:\/\/doi.org\/10.1182\/blood.2021011958","journal-title":"Blood"},{"key":"5563_CR17","doi-asserted-by":"publisher","first-page":"e071594","DOI":"10.1136\/bmj-2022-071594","volume":"379","author":"X Li","year":"2022","unstructured":"Li X, Burn E, Duarte-Salles T et al (2022) Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ 379:e071594. https:\/\/doi.org\/10.1136\/bmj-2022-071594","journal-title":"BMJ"},{"issue":"10269","key":"5563_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397(10269):99\u2013111. https:\/\/doi.org\/10.1016\/s0140-6736(20)32661-1","journal-title":"Lancet"},{"issue":"4","key":"5563_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00277-023-05136-2","volume":"102","author":"JW Jacobs","year":"2023","unstructured":"Jacobs JW, Booth GS, Adkins BD (2023) Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination. Ann Hematol 102(4):955\u2013959. https:\/\/doi.org\/10.1007\/s00277-023-05136-2","journal-title":"Ann Hematol"},{"issue":"10","key":"5563_CR20","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.7326\/m21-2680","volume":"174","author":"AM Pishko","year":"2021","unstructured":"Pishko AM, Cuker A (2021) Thrombosis after vaccination with messenger RNA-1273: is this vaccine-induced thrombosis and thrombocytopenia or thrombosis with thrombocytopenia syndrome? Ann Intern Med 174(10):1468\u20131469. https:\/\/doi.org\/10.7326\/m21-2680","journal-title":"Ann Intern Med"},{"issue":"10","key":"5563_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.7326\/l21-0244","volume":"174","author":"S Sangli","year":"2021","unstructured":"Sangli S, Virani A, Cheronis N et al (2021) Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine. Ann Intern Med 174(10):1480\u20131482. https:\/\/doi.org\/10.7326\/l21-0244","journal-title":"Ann Intern Med"},{"issue":"23","key":"5563_CR22","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMe2106315","volume":"384","author":"DB Cines","year":"2021","unstructured":"Cines DB, Bussel JB (2021) SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med 384(23):2254\u20132256. https:\/\/doi.org\/10.1056\/NEJMe2106315","journal-title":"N Engl J Med"},{"issue":"10","key":"5563_CR23","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00277-022-04909-5","volume":"101","author":"P Murphy","year":"2022","unstructured":"Murphy P (2022) Venous thromboembolism after COVID-19 mRNA vaccination. Ann Hematol 101(10):2363\u20132363. https:\/\/doi.org\/10.1007\/s00277-022-04909-5","journal-title":"Ann Hematol"},{"issue":"2","key":"5563_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.seminhematol.2022.02.002","volume":"59","author":"M Pai","year":"2022","unstructured":"Pai M (2022) Epidemiology of VITT. Semin Hematol 59(2):72\u201375. https:\/\/doi.org\/10.1053\/j.seminhematol.2022.02.002","journal-title":"Semin Hematol"},{"key":"5563_CR25","unstructured":"Oliver SE (2021) Risk\/benefit assessment of thrombotic thrombocytopenic events after janssen COVID-19 vaccines: applying evidence to recommendation framework. ACIP meeting COVID-19 Vaccines. https:\/\/stacks.cdc.gov\/view\/cdc\/107511"},{"issue":"8","key":"5563_CR26","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jth.15362","volume":"19","author":"S Platton","year":"2021","unstructured":"Platton S, Bartlett A, MacCallum P et al (2021) Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 19(8):2007\u20132013. https:\/\/doi.org\/10.1111\/jth.15362","journal-title":"J Thromb Haemost"},{"issue":"2","key":"5563_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/0005-2795(75)90144-0","volume":"379","author":"S Moore","year":"1975","unstructured":"Moore S, Pepper DS, Cash JD (1975) Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochim Biophys Acta 379(2):370\u2013384","journal-title":"Biochim Biophys Acta"},{"issue":"1-2","key":"5563_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000015209","volume":"84","author":"N O\u2019Donovan","year":"1999","unstructured":"O\u2019Donovan N, Galvin M, Morgan J (1999) Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet Cell Genet 84(1-2):39\u201342","journal-title":"Cytogenet Cell Genet"},{"issue":"2","key":"5563_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1182\/blood.V76.2.336.336","volume":"76","author":"R Eisman","year":"1990","unstructured":"Eisman R, Surrey S, Ramachandran B, Schwartz E, Poncz M (1990) Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. Blood 76(2):336\u2013344","journal-title":"Blood"},{"issue":"4","key":"5563_CR30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","volume":"117","author":"K Krauel","year":"2011","unstructured":"Krauel K, P\u00f6tschke C, Weber C et al (2011) Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood 117(4):1370\u20131378. https:\/\/doi.org\/10.1182\/blood-2010-08-301424","journal-title":"Blood"},{"issue":"22","key":"5563_CR31","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood.2021013231","volume":"138","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Selleng K, Palankar R et al (2021) Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood 138(22):2256\u20132268. https:\/\/doi.org\/10.1182\/blood.2021013231","journal-title":"Blood"},{"issue":"1","key":"5563_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood.V96.1.188","volume":"96","author":"M Hughes","year":"2000","unstructured":"Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG (2000) Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 96(1):188\u2013194","journal-title":"Blood"},{"issue":"5","key":"5563_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/jth.15265","volume":"19","author":"P Patel","year":"2021","unstructured":"Patel P, Michael JV, Naik UP, McKenzie SE (2021) Platelet Fc\u03b3RIIA in immunity and thrombosis: adaptive immunothrombosis. J Thromb Haemost 19(5):1149\u20131160. https:\/\/doi.org\/10.1111\/jth.15265","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5563_CR34","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","volume":"10","author":"J Perdomo","year":"2019","unstructured":"Perdomo J, Leung HHL, Ahmadi Z et al (2019) Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun 10(1):1322. https:\/\/doi.org\/10.1038\/s41467-019-09160-7","journal-title":"Nat Commun"},{"issue":"10249","key":"5563_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu FC, Guan XH, Li YH et al (2020) Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 396(10249):479\u2013488. https:\/\/doi.org\/10.1016\/s0140-6736(20)31605-6","journal-title":"Lancet"},{"issue":"1","key":"5563_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/blood.2021014588","volume":"140","author":"AJ Kanack","year":"2022","unstructured":"Kanack AJ, Bayas A, George G et al (2022) Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT. Blood 140(1):73\u201377. https:\/\/doi.org\/10.1182\/blood.2021014588","journal-title":"Blood"},{"key":"5563_CR37","doi-asserted-by":"publisher","first-page":"779453","DOI":"10.3389\/fimmu.2021.779453","volume":"12","author":"SR Ostrowski","year":"2021","unstructured":"Ostrowski SR, S\u00f8gaard OS, Tolstrup M et al (2021) Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front Immunol 12:779453. https:\/\/doi.org\/10.3389\/fimmu.2021.779453","journal-title":"Front Immunol"},{"issue":"5","key":"5563_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/blood.2021014712","volume":"140","author":"L Nicolai","year":"2022","unstructured":"Nicolai L, Leunig A, Pekayvaz K et al (2022) Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration. Blood 140(5):478\u2013490","journal-title":"Blood"},{"issue":"2","key":"5563_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/bjh.18245","volume":"198","author":"E Petito","year":"2022","unstructured":"Petito E, Colonna E, Falcinelli E et al (2022) Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers. Br J Haematol 198(2):257\u2013266","journal-title":"Br J Haematol"},{"issue":"1","key":"5563_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","volume":"125","author":"A Padmanabhan","year":"2015","unstructured":"Padmanabhan A, Jones CG, Bougie DW et al (2015) Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. Blood 125(1):155\u2013161","journal-title":"Blood"},{"issue":"7873","key":"5563_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","volume":"596","author":"A Huynh","year":"2021","unstructured":"Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I (2021) Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature 596(7873):565\u2013569","journal-title":"Nature"},{"issue":"2","key":"5563_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jth.14369","volume":"17","author":"A Huynh","year":"2019","unstructured":"Huynh A, Arnold DM, Kelton JG et al (2019) Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. J Thromb Haemost 17(2):389\u2013399. https:\/\/doi.org\/10.1111\/jth.14369","journal-title":"J Thromb Haemost"},{"issue":"15","key":"5563_CR43","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1182\/blood.2022016474","volume":"140","author":"JJ Wang","year":"2022","unstructured":"Wang JJ, Armour B, Chataway T et al (2022) Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody. Blood 140(15):1738\u20131742. https:\/\/doi.org\/10.1182\/blood.2022016474","journal-title":"Blood"},{"issue":"3","key":"5563_CR44","doi-asserted-by":"publisher","first-page":"e12707","DOI":"10.1002\/rth2.12707","volume":"6","author":"SJ Montague","year":"2022","unstructured":"Montague SJ, Smith CW, Lodwick CS et al (2022) Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: persistent positivity through 7 months. Res Pract Thromb Haemost 6(3):e12707","journal-title":"Res Pract Thromb Haemost"},{"issue":"16","key":"5563_CR45","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/blood.2021014684","volume":"139","author":"B Craven","year":"2022","unstructured":"Craven B, Lester W, Boyce S et al (2022) Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis. Blood 139(16):2553\u20132560. https:\/\/doi.org\/10.1182\/blood.2021014684","journal-title":"Blood"},{"issue":"12","key":"5563_CR46","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2021014214","volume":"139","author":"L Sch\u00f6nborn","year":"2022","unstructured":"Sch\u00f6nborn L, Thiele T, Kaderali L et al (2022) Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient. Blood 139(12):1903\u20131907. https:\/\/doi.org\/10.1182\/blood.2021014214","journal-title":"Blood"},{"issue":"17","key":"5563_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/nejm200104263441704","volume":"344","author":"TE Warkentin","year":"2001","unstructured":"Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344(17):1286\u20131292. https:\/\/doi.org\/10.1056\/nejm200104263441704","journal-title":"N Engl J Med"},{"key":"5563_CR48","doi-asserted-by":"publisher","first-page":"n2195","DOI":"10.1136\/bmj.n2195","volume":"375","author":"S Pavord","year":"2021","unstructured":"Pavord S, Hunt BJ, Horner D, Bewley S, Karpusheff J (2021) Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance. BMJ 375:n2195. https:\/\/doi.org\/10.1136\/bmj.n2195","journal-title":"BMJ"},{"issue":"07","key":"5563_CR49","first-page":"095","volume":"68","author":"J Amiral","year":"1992","unstructured":"Amiral J, Bridey F, Dreyfus M et al (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68(07):095\u2013096","journal-title":"Thromb Haemost"},{"issue":"2","key":"5563_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2141.1999.01717.x","volume":"107","author":"PM Newman","year":"1999","unstructured":"Newman PM, Chong BH (1999) Further characterization of antibody and antigen in heparin-induced thrombocytopenia. Br J Haematol 107(2):303\u2013309","journal-title":"Br J Haematol"},{"issue":"8","key":"5563_CR51","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","volume":"6","author":"TE Warkentin","year":"2008","unstructured":"Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG (2008) Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost 6(8):1304\u20131312. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03025.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5563_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1067\/mlc.2001.115525","volume":"138","author":"GP Visentin","year":"2001","unstructured":"Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH (2001) Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis. J Lab Clin Med 138(1):22\u201331. https:\/\/doi.org\/10.1067\/mlc.2001.115525","journal-title":"J Lab Clin Med"},{"issue":"2","key":"5563_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.seminhematol.2022.03.003","volume":"59","author":"TE Warkentin","year":"2022","unstructured":"Warkentin TE, Greinacher A (2022) Laboratory testing for VITT antibodies. Semin Hematol 59(2):80\u201388. https:\/\/doi.org\/10.1053\/j.seminhematol.2022.03.003","journal-title":"Semin Hematol"},{"key":"5563_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-0716-3175-1_26","volume":"2663","author":"EJ Favaloro","year":"2023","unstructured":"Favaloro EJ, Pasalic L (2023) Heparin-induced thrombotic thrombocytopenia (HITT) and vaccine-induced immune thrombotic thrombocytopenia (VITT): similar but different. Methods Mol Biol 2663:405\u2013415. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_26","journal-title":"Methods Mol Biol"},{"issue":"12","key":"5563_CR55","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1111\/jth.15881","volume":"20","author":"EJ Favaloro","year":"2022","unstructured":"Favaloro EJ, Clifford J, Leitinger E et al (2022) Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: a multicenter study comprising 1284 patients. J Thromb Haemost 20(12):2896\u20132908. https:\/\/doi.org\/10.1111\/jth.15881","journal-title":"J Thromb Haemost"},{"issue":"7","key":"5563_CR56","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/jth.15352","volume":"19","author":"IH S\u00f8rvoll","year":"2021","unstructured":"S\u00f8rvoll IH, Horvei KD, Ernstsen SL et al (2021) An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination. J Thromb Haemost 19(7):1813\u20131818. https:\/\/doi.org\/10.1111\/jth.15352","journal-title":"J Thromb Haemost"},{"issue":"4","key":"5563_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood.2021012217","volume":"138","author":"T Thiele","year":"2021","unstructured":"Thiele T, Ulm L, Holtfreter S et al (2021) Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. Blood 138(4):299\u2013303. https:\/\/doi.org\/10.1182\/blood.2021012217","journal-title":"Blood"},{"issue":"4","key":"5563_CR58","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/ijlh.13629","volume":"43","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ (2021) Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Int J Lab Hematol 43(4):559\u2013570. https:\/\/doi.org\/10.1111\/ijlh.13629","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"5563_CR59","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ajh.26488","volume":"97","author":"AJ Kanack","year":"2022","unstructured":"Kanack AJ, Singh B, George G et al (2022) Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. Am J Hematol 97(5):519\u2013526","journal-title":"Am J Hematol"},{"issue":"19","key":"5563_CR60","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJMc2112760","volume":"385","author":"L Sch\u00f6nborn","year":"2021","unstructured":"Sch\u00f6nborn L, Thiele T, Kaderali L, Greinacher A (2021) Decline in pathogenic antibodies over time in VITT. N Engl J Med 385(19):1815\u20131816","journal-title":"N Engl J Med"},{"key":"5563_CR61","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.lanepe.2021.100270","volume":"12","author":"T Thiele","year":"2022","unstructured":"Thiele T, Weisser K, Sch\u00f6nborn L et al (2022) Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Lancet Reg Health Eur 12:100270. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100270","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"5563_CR62","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","volume":"107","author":"A Greinacher","year":"2022","unstructured":"Greinacher A, Langer F, Schonborn L et al (2022) Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy. Haematologica 107(5):1219\u20131221. https:\/\/doi.org\/10.3324\/haematol.2021.280366","journal-title":"Haematologica"},{"issue":"6","key":"5563_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/ejh.13855","volume":"109","author":"FI Danish","year":"2022","unstructured":"Danish FI, Rabani AE, Subhani FE, Yasmin S, Koul SS (2022) COVID-19: vaccine-induced immune thrombotic thrombocytopenia. Eur J Haematol 109(6):619\u2013632. https:\/\/doi.org\/10.1111\/ejh.13855","journal-title":"Eur J Haematol"},{"key":"5563_CR64","unstructured":"Bussel JB, Connors JM, Cines DB et al (5.9.2022) Vaccine-induced immune thrombotic thrombocytopenia. Am Soc Hematol. https:\/\/www.hematology.org\/covid-19\/vaccine-induced-immune-thrombotic-thrombocytopenia. 8.6.2023"},{"issue":"23","key":"5563_CR65","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/bloodadvances.2019000617","volume":"3","author":"L Goldmann","year":"2019","unstructured":"Goldmann L, Duan R, Kragh T et al (2019) Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03b3RIIA): a new option in HIT? Blood Adv 3(23):4021\u20134033. https:\/\/doi.org\/10.1182\/bloodadvances.2019000617","journal-title":"Blood Adv"},{"issue":"11","key":"5563_CR66","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1055\/a-1481-3039","volume":"121","author":"P von Hundelshausen","year":"2021","unstructured":"von Hundelshausen P, Lorenz R, Siess W, Weber C (2021) Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thromb Haemost 121(11):1395\u20131399. https:\/\/doi.org\/10.1055\/a-1481-3039","journal-title":"Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05563-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T15:03:36Z","timestamp":1701356616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05563-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":66,"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05563-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}